The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19
1 other identifier
interventional
100
1 country
1
Brief Summary
Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2020
CompletedFirst Submitted
Initial submission to the registry
May 21, 2020
CompletedFirst Posted
Study publicly available on registry
May 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2020
CompletedMay 22, 2020
May 1, 2020
3 months
May 21, 2020
May 21, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of viral pneumonia caused by COVID 19
Efficacy of POCUS on diagnosis of viral pneumonia caused by COVID 19
3 months
Study Arms (1)
Suspected COVID-19 Group
OTHERPatients who admitted to emergency department with suspicion of COVID 19 pneumonia will be evaluated with POCUS/ bedside lung ultrasound.
Interventions
Point of care ultrasound will be used as bedside lung ultrasound to determine the patients if they have a COVID-19 pneumonia.
Eligibility Criteria
You may qualify if:
- All patients with an informed consent
- Admission to emergency department with symptoms or signs of COVID-19
You may not qualify if:
- Absence of informed consent
- Patients under age of 18
- Presence of acute coronary syndrome
- Presence of chronic lung disease
- Pregnancy
- Presence of trauma
- Patients with a diagnosis of malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, 34303, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 21, 2020
First Posted
May 22, 2020
Study Start
May 10, 2020
Primary Completion
August 10, 2020
Study Completion
September 10, 2020
Last Updated
May 22, 2020
Record last verified: 2020-05